Pasireotide: a novel treatment for patients with acromegaly

Morbidity and mortality rates in patients with active acromegaly are higher than the general population. Adequate biochemical control restores mortality to normal rates. Now, medical therapy has an increasingly important role in the treatment of patients with acromegaly. Somatostatin receptor ligand...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuevas-Ramos, Daniel, Fleseriu, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714742/
https://www.ncbi.nlm.nih.gov/pubmed/26811671
http://dx.doi.org/10.2147/DDDT.S77999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4714742/
https://www.ncbi.nlm.nih.gov/pubmed/26811671
http://dx.doi.org/10.2147/DDDT.S77999

Ejemplares similares